Molecular basis for oncogenic signaling via Wnt-receptor pseudokinases
Bidragets beskrivning
Ovarian cancer (OC) is one of the most common gynecologic cancers that also has high mortality rate. This is due to resistant and metastatic forms of the disease that causes relapsing. Hence, there is an urgent need for new effective treatments for OC. Interestingly, it has been found that OC cells, among other types of cancer cells, have high expression of receptors that bind Wnt ligands, such as tyrosine kinase-like orphan receptor 1 and 2 (ROR1 and 2) and protein tyrosine kinase 7 (PTK7), which are not expressed at high levels in healthy adult tissues. My projects will give insight of how these Wnt-signaling receptors drive cancer progression and how by targeting their expression we could stop cancer growth. We use OC cell lines and patient-derived cells to study the oncogenic events driven by these receptors, including genes and signaling cascades they alter. In parallel, we will develop molecules that bind explicitly to these tumor-specific receptors and block their function.
Visa merStartår
2022
Slutår
2026
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Forskardoktorer
Utlysning
Beslutfattare
Forskningsrådet för biovetenskap, hälsa och miljö
28.04.2022
28.04.2022
Övriga uppgifter
Finansieringsbeslutets nummer
349787
Vetenskapsområden
Biokemi, cell- och molekylärbiologi
Forskningsområden
Biokemia, biofysiikka
Identifierade teman
cancer